Cepheid Stock Sees Short Interest Decrease By 10.3%

The most recent short interest data has been released by the NASDAQ for the 04/15/2014 settlement date, which shows a 1,016,852 share decrease in total short interest for Cepheid ( CPHD), to 8,851,615, a decrease of 10.30% since 03/31/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for CPHD at the 04/15/2014 settlement increased to 775,091, as compared to 642,180 at the 03/31/2014 report. That brought "days to cover" down to 11.42, a 25.68% decrease from the 15.37 days to cover calculated at the previous short interest data release.

The below chart shows the historical "days to cover" for CPHD at previous short interest release dates:

Top 25 S.A.F.E. Dividend Stocks »


A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where CPHD had been shorted as a hedge.

The chart below shows the one year performance of CPHD shares, versus its 200 day moving average. Looking at this chart, CPHD's low point in its 52 week range is $30.95 per share, with $55.89 as the 52 week high point — that compares with a last trade of $42.14.

If you liked this article you might like

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird

Cepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Jim Cramer's 'Mad Money' Recap: These Stocks Will Rise, Whatever the Fed Does